SPC503
Delgocitinib á öllum formum sem eru vernduð af grunneinkaleyfinu / Delgocitinib in all forms protected by the basic patent
:
Umsókn:
27.2.2025:
15.3.2025
:
Anzupgo
27.2.2025
15.3.2025
:
EU/1/24/1851:
15.10.2024
:
EU/1/24/1851:
19.9.2024
:
Japan Tobacco, Inc.:
1-1, Toranomon 4-chome, Minato-ku, Tokyo JP
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113 Reykjavík